Follow
Mark Barszczyk
Mark Barszczyk
Unknown affiliation
Verified email at mail.utoronto.ca
Title
Cited by
Cited by
Year
Epigenomic alterations define lethal CIMP-positive ependymomas of infancy
SC Mack, H Witt, RM Piro, L Gu, S Zuyderduyn, AM Stütz, X Wang, ...
Nature 506 (7489), 445-450, 2014
6292014
Genomic analysis of diffuse intrinsic pontine gliomas identifies three molecular subgroups and recurrent activating ACVR1 mutations
P Buczkowicz, C Hoeman, P Rakopoulos, S Pajovic, L Letourneau, ...
Nature genetics 46 (5), 451-456, 2014
6182014
Integrated (epi)-genomic analyses identify subgroup-specific therapeutic targets in CNS rhabdoid tumors
J Torchia, B Golbourn, S Feng, KC Ho, P Sin-Chan, A Vasiljevic, ...
Cancer cell 30 (6), 891-908, 2016
2212016
TERT promoter mutations are highly recurrent in SHH subgroup medulloblastoma
M Remke, V Ramaswamy, J Peacock, DJH Shih, C Koelsche, ...
Acta neuropathologica 126, 917-929, 2013
1992013
CNS-PNETs with C19MC amplification and/or LIN28 expression comprise a distinct histogenetic diagnostic and therapeutic entity
T Spence, P Sin-Chan, D Picard, M Barszczyk, K Hoss, M Lu, SK Kim, ...
Acta neuropathologica 128, 291-303, 2014
1652014
ATM regulates 3-methylpurine-DNA glycosylase and promotes therapeutic resistance to alkylating agents
S Agnihotri, K Burrell, P Buczkowicz, M Remke, B Golbourn, ...
Cancer discovery 4 (10), 1198-1213, 2014
762014
Alternative lengthening of telomeres is enriched in, and impacts survival of TP53 mutant pediatric malignant brain tumors
J Mangerel, A Price, P Castelo-Branco, J Brzezinski, P Buczkowicz, ...
Acta neuropathologica 128, 853-862, 2014
562014
Spinal myxopapillary ependymomas demonstrate a Warburg phenotype
SC Mack, S Agnihotri, KC Bertrand, X Wang, DJ Shih, H Witt, N Hill, ...
Clinical Cancer Research 21 (16), 3750-3758, 2015
502015
Telomerase inhibition abolishes the tumorigenicity of pediatric ependymoma tumor-initiating cells
M Barszczyk, P Buczkowicz, P Castelo-Branco, SC Mack, V Ramaswamy, ...
Acta neuropathologica 128, 863-877, 2014
422014
Ependymoma
LM Hoffman, AM Donson, I Nakachi, AM Griesinger, DK Birks, V Amani, ...
Neuro Oncol 16 (Suppl_1), i17-i25, 2014
22014
Telomerase as a prognostic marker and therapeutic target in paediatric ependymoma
M Barszczyk
12013
Targeting the base excision repair pathway to overcome therapeutic resistance to alkylating agents in pediatric glioblastoma
S Agnihotri, K Burrell, P Buczkowicz, M Remke, B Golbourn, ...
Canadian Journal of Neurological Sciences 41 (s2), S5-S6, 2014
2014
C19MC AMPLIFIED TUMOURS: A NEW HISTO-GENETIC AND DIAGNOSTIC ENTITY
T Spence, D Picard, M Barszczyk, SK Kim, YS Ra, J Fangusaro, ...
NEURO-ONCOLOGY 15, 170-170, 2013
2013
EXPERIMENTAL THERAPEUTICS AND PHARMACOLOGY
C Aaberg-Jessen, L Fogh, B Halle, V Jensen, N Brünner, B Kristensen, ...
Neuro-oncology 15 (Suppl 3), iii37-iii61, 2013
2013
PEDIATRICS CLINICAL RESEARCH
R Antony, M Al-Rahawan, M Zagardo, M Gujrati, J Lin, A Broniscer, ...
Neuro-oncology 15 (Suppl 3), iii165-iii172, 2013
2013
Targeting DNA Damage Response Pathways to Overcome Alkylating Agent Resistance in Pediatric Glioblastoma
C Hawkins, K Burrell, N Fernandez, I Clarke, M Barszczyk, N Sabha, ...
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY 72 (6), 573-574, 2013
2013
EFFECTIVE EPIGENETIC THERAPY FOR CIMP plus POSTERIOR FOSSA EPENDYMOMA
S Mack, H Witt, N Jager, S Zuyderduyn, K Nethery-Brokx, L Garzia, ...
NEURO-ONCOLOGY 15, 22-22, 2013
2013
Targeting DNA Damage Response Pathways to Overcome Alkylating Agent Resistance in Pediatric Glioblastoma
S Agnihotri, K Burrell, N Fernandez, B Golbourn, I Clarke, M Barrzczyk, ...
NEURO-ONCOLOGY 15, 27-28, 2013
2013
Telomerase inhibition induces growth arrest in paediatric ependymoma
M Barszczyk, P Buczkowicz, P Castelo-Branco, S Mack, K Nethery-Brokx, ...
NEURO-ONCOLOGY 15, 7-7, 2013
2013
TELOMERASE INHIBITION INDUCES GROWTH ARREST IN PAEDIATRIC EPENDYMOMA
M Barszczyk, P Buczkowicz, A Morrison, U Tabori, C Hawkins
NEURO-ONCOLOGY 14, 39-39, 2012
2012
The system can't perform the operation now. Try again later.
Articles 1–20